Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile
go back to main search page
Accession:CHEBI:122203 term browser browse the term
Definition:A phenol that has formula C18H22N2O2S.
Synonyms:related_synonym: Formula=C18H22N2O2S;   InChI=1S/C18H22N2O2S/c1-2-3-4-5-10-23-18-16(12-19)15(11-17(22)20-18)13-6-8-14(21)9-7-13/h6-9,15,21H,2-5,10-11H2,1H3,(H,20,22);   InChIKey=HYBLKCYMQMUZPK-UHFFFAOYSA-N;   SMILES=CCCCCCSC1=C(C(CC(=O)N1)C2=CC=C(C=C2)O)C#N
 xref: LINCS:LSM-33646


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20965
    chemical entity 20963
      molecular entity 20952
        polyatomic entity 20802
          heteroatomic molecular entity 20684
            hydroxides 19750
              organic hydroxy compound 18849
                phenols 18223
                  6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20965
    subatomic particle 20959
      composite particle 20959
        hadron 20959
          baryon 20959
            nucleon 20959
              atomic nucleus 20959
                atom 20959
                  main group element atom 20796
                    p-block element atom 20796
                      carbon group element atom 20536
                        carbon atom 20512
                          organic molecular entity 20512
                            organic molecule 20364
                              organic cyclic compound 20043
                                organic aromatic compound 19571
                                  phenols 18223
                                    6-(hexylthio)-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1H-pyridine-5-carbonitrile 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.